Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (54)

2024

  1. Delphi consensus on the transition from paediatric to adult epilepsy care

    Neurology Perspectives, Vol. 4, Núm. 2

  2. Relevancia de la adhesión al tratamiento en el control de la epilepsia

    Revista de Neurologia, Vol. 78, Núm. 8, pp. 237

2023

  1. Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late-onset cerebellar ataxia

    European Journal of Neurology, Vol. 30, Núm. 12, pp. 3828-3833

  2. Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 479-503

2022

  1. Melatonin in sleep disorders

    Neurologia, Vol. 37, Núm. 7, pp. 575-585

2021

  1. Relationship between sleep quality and cognitive performance in patients with epilepsy

    Epilepsy and Behavior, Vol. 122

2020

  1. Diagnóstico y tratamiento de los insomnios en las personas mayores

    Kranion, Vol. 15, Núm. 3, pp. 104-109

  2. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119

  3. Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study

    European Journal of Neurology, Vol. 27, Núm. 8, pp. 1364-1373

  4. Sleep-related movement and behavioural disorders in adults

    Revista de Neurologia, Vol. 71, Núm. 10, pp. 377-386

  5. Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain

    Genes, Vol. 11, Núm. 5

2019

  1. Actininopathy: A new muscular dystrophy caused by ACTN2 dominant mutations

    Annals of Neurology, Vol. 85, Núm. 6, pp. 899-906

  2. Epilepsia y depresión

    Kranion, Vol. 14, Núm. 1, pp. 17-23

  3. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

  4. Perampanel como terapia añadida precoz en el tratamiento de la epilepsia

    Revista de neurologia, Vol. 69, Núm. s01

2018

  1. Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis

    Journal of the Neurological Sciences

  2. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area

    Neurologia, Vol. 33, Núm. 9, pp. 583-589

  3. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting

    Epilepsy Research, Vol. 145, pp. 51-54

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research